NAFLD in type 1 diabetes: overrated or underappreciated?
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in western countries, affecting 25–30% of the general population and up to 65% in those with obesity and/or type 2 diabetes. Accumulation of visceral adipose tissue and insulin resistance (IR) contributes to NAFLD. NAF...
Enregistré dans:
Auteurs principaux: | Jonathan Mertens, Luc F. Van Gaal, Sven M. Francque, Christophe De Block |
---|---|
Format: | article |
Langue: | EN |
Publié: |
SAGE Publishing
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/309a074d7b7f4f34b4d8166ab91feff0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Maturity-Onset Diabetes of Young Type 5: Diabetes with Extrapancreatic Features
par: Adnan Haider, et autres
Publié: (2021) -
Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
par: Peter Rossing, et autres
Publié: (2021) -
Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
par: Giesje Nefs, et autres
Publié: (2021) -
Plasma protein N-glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes
par: Femke Rutters, et autres
Publié: (2021) -
The Effect of Liraglutide on Epicardial Adipose Tissue in Type 2 Diabetes
par: Na Zhao, et autres
Publié: (2021)